How New Red Cell Antigens Are Identified, Classified, Added to a Blood Group System. or Creating a New Blood Group System, Theory, and Practice
8:15 AM - 9:15 AM PT
AM25-TU-01-L - How New Red Cell Antigens Are Identified, Classified, Added to a Blood Group System. or Creating a New Blood Group System, Theory, and Practice
Biotherapies/Cellular Therapies and Immunotherapies - Hematopoietic Cell Therapy/Transplant Immunotherapies (includes CAR T cells)
9:30 AM - 11:00 AM PT
#OA2-AM25-TU-15 - Lack of Transfusion Independence by Day 30 After Allogeneic Hematopoietic Cell Transplant Is Associated with Increased Non-Relapse Mortality Independent of HCT-CI in Acute Myeloid Leukemia Patients
Cell Biology/Immunology and Biochemistry (Basic and Preclinical Research) - Platelets
9:30 AM - 11:00 AM PT
AM25-TU-20-L - Oral Abstract Session - Therapeutic and Donor Apheresis and Blood Donation Infectious Disease
9:30 AM - 11:00 AM PT
AM25-TU-20-L - Oral Abstract Session - Therapeutic and Donor Apheresis and Blood Donation Infectious Disease
Room: SDCC 28BCDE
9:30 AM - 11:00 AM PT
#OA2-AM25-TU-20 - Blood Exchange Transfusion as a Novel Immunotherapy in Systemic Lupus Erythematosus
Room: SDCC 28BCDE
Presenting Author: Ning Li (he/him/his) – Department of Blood Transfusion, Xiangya Hospital, NHC Key Laboratory of Cancer Proteomics, Central South University, Changsha, Hunan Province, China
Therapeutic Apheresis
9:30 AM - 11:00 AM PT
#OA1-AM25-TU-20 - Evaluation of Lymphoplasmapheresis as a Novel Therapy for Efficacy and Immunomodulatory Mechanisms in Neuromyelitis Optica Spectrum Disorder
Room: SDCC 28BCDE
Presenting Author: Siya Pei, 0009-0007-9628-7024 (she/her/hers) – Department of Blood Transfusion, Xiangya Hospital, NHC Key Laboratory of Cancer Proteomics, Central South University, Changsha, Hunan Province, China
Therapeutic Apheresis
9:30 AM - 11:00 AM PT
#OA4-AM25-TU-20 - HIV Incidence and Factors Associated with Recent Infection Among Blood Donors in Brazil Following Adoption of Individual Donor Assessment